🔆 📖 👤

Statutory Instruments

2005 No. 1094

MEDICINES

The Medicines (Advisory Bodies) Regulations 2005

Made

4th April 2005

Laid before Parliament

7th April 2005

Coming into force

For the purposes of making regulations under paragraph 6 of Schedule 1A to the Medicines Act 1968, as inserted by regulation 7

31st May 2005

For all other purposes

30th October 2005

The Secretary of State, being a Minister designated(1) for the purposes of section 2(2) of the European Communities Act 1972(2) in relation to medicinal products, in exercise of the powers conferred by the said section 2(2), and of all other powers enabling him in that behalf, hereby makes the following Regulations:

Citation, commencement and interpretation

F11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Abolition of the Medicines Commission

F12. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Establishment of the Commission on Human Medicines

F13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Functions of the Commission on Human Medicines

F14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of section 4 of the Act

F15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of section 5 of the Act

F16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Provisions relating to Commission on Human Medicines and other committees

F17. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Consequential and other amendments to the ActI1

8. The amendments to the Act set out in Schedule 1 shall have effect.

Consequential and other amendments to the Marketing Authorisation Regulations

F19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendments to other enactments

F110. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Revocations

F111. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Transfer of properties, rights and liabilities

F112. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signed by authority of the Secretary of State for Health

Warner

Parliamentary Under Secretary of State,

Department of Health

4th April 2005

Regulation 8

SCHEDULE 1AMENDMENTS TO THE MEDICINES ACT 1968I2

F11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F12. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F16. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F17. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F18. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F110. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F111. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12.—(1) Section 62 of the Act (prohibition of sale, supply, or importation, of certain medicinal products) shall be amended as follows.

F1(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4) In subsection (5), for “Commission” (at each place where it occurs) substitute “appropriate committee”.

(5) For subsection (7) substitute—

(7)If an order is made under this section and either—

(a)the appropriate committee have not considered the proposal to make the order, or

(b)the order is made contrary to the advice of the appropriate committee,

the order shall include a statement of the fact that it has been so made..

F113. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F114. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F115. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Regulation 9

F1SCHEDULE 2CONSEQUENTIAL AND OTHER AMENDMENTS TO THE MARKETING AUTHORISATION REGULATIONS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Regulation 10

F1SCHEDULE 3AMENDMENTS TO OTHER ENACTMENTS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(3)

OJ L311, 28.11.2001, p.67.

(4)

OJ L136, 30.4.2004, p.34.

Status: There are currently no known outstanding effects for The Medicines (Advisory Bodies) Regulations 2005.
The Medicines (Advisory Bodies) Regulations 2005 (2005/1094)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regulations revoked (except for reg. 8 , Sch. 1 para. 12(1)(4)(5)) (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
I1Reg. 8 in force at 30.10.2005, see reg. 1(1)
I2Sch. 1 para. 12 in force at 30.10.2005, see reg. 1(1)
Defined TermSection/ArticleIDScope of Application
This instrument is derived from the version at www.legislation.gov.uk. To see a list of all amendments (including any to be made) check the resources page for this instrument on their website. Note, the status of this instrument is given above.
This instrument is derived from the version at www.legislation.gov.uk. To see original commencement information, check the resources page associated with this instrument. n.b. commencement information for marked amendments is embedded in the relevant footnote.

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.